Schedule 13G/A Filing for Inogen Inc. by The Vanguard Group

The Vanguard Group, Inc. has filed a Schedule 13G/A amendment regarding its holdings in Inogen Inc. This filing indicates a change in reporting due to an internal realignment of certain subsidiaries and business divisions. Following this realignment, these entities will now report their beneficial ownership separately from The Vanguard Group, Inc. The filing asserts that these subsidiaries and divisions continue to employ the same investment strategies. Consequently, The Vanguard Group, Inc. no longer claims beneficial ownership over securities held by these disaggregated entities. The filing also states that no single person, other than Vanguard, has an interest exceeding 5% in the reported securities. The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer.